Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided intra-articular ozone plus Compound Angelica or sodium hyaluronate for knee osteoarthritis
ChiCTR2200066661Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of compound angelica sinensis injection, cyanocobalamin, sodium hyaluronate and medical ozonated water in knee osteoarthritis (OA) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: visual analog scale for pain. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
compound angelica sinensis injectioncyanocobalaminsodium hyaluronatemedical ozonated water
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200066661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066661.